Industrialisation of a breath-actuated inhaler
Challenge
We supported our client with the industrialisation and scale-up of a breath-actuated pressurised metered dose inhaler (pMDI) for the treatment of asthma.
Approach
We worked with our client as device design partners, integrating closely with several functions across the client organisation and a large number of partners including manufacturing organisations, specialist equipment suppliers and regulatory experts, to bring the device to market.
Outcome
The product was launched in Europe in 2018 as an asthma treatment for adults and adolescents.